VA-SenaSeptember 29, 2020
Ever since the senior BJP leader tweeted about her testing positive for the infection late on Saturday night, the AIIMS management had made arrangements, in-charge of COVID cases at the AIIMS, Madhur Uniyal, said.
Rishikesh: Former Union minister and senior BJP leader Uma Bharti, who tested positive for COVID-19 recently, was on Monday admitted to the All India Institute of Medical Sciences (AIIMS) in Rishikesh.
VA-SenaSeptember 21, 2020
“The second round of countrywide serosurvey led by ICMR has been successfully completed. The final phase analysis of the survey is now underway and will offer a comparison with the results of the first survey #IndiaFightsCOVID19,” the ICMR said in a tweet.
New Delhi [India]: The Indian Council of Medical Research (ICMR) on Sunday informed that the second round of the countrywide serosurvey for COVID-19 has been successfully completed and the final phase analysis of the survey is now underway.
“The second round of countrywide serosurvey led by ICMR has been successfully completed. The final phase analysis of the survey is now underway and will offer a comparison with the results of the first survey #IndiaFightsCOVID19,” the ICMR said in a tweet.
According to the Council, the containment zones, that refer to a specific geographical area where positive cases of coronavirus are found are dynamic in nature and they do not fit into nationally representative sampling
VA-SenaSeptember 18, 2020
The health ministry’s Covid-19 dashboard showed there were 1,017,754 active cases and the country’s death toll has gone up to 84,372.
India’s coronavirus disease (Covid-19) tally surged to 5,214,677 after 96,424 new cases and 1,174 deaths were reported in the last 24 hours from across the country, according to the Union health ministry on Friday.
The health ministry’s Covid-19 dashboard showed there were 1,017,754 active cases and the country’s death toll has gone up to 84,372.
Close to half or 48.45% of the active cases of Covid-19 are concentrated in three states of Maharashtra, Karnataka and Andhra Pradesh, the ministry said on Thursday. Along with Uttar Pradesh and Tamil Nadu, these states contribute nearly 60% of the total active cases in the country, it added.
According to the health ministry’s dashboard at 8am, 87,472 Covid-19 patients recovered between Thursday and Friday morning. With this, the number of recoveries in India has climbed to 4,112,551 and the recovery rate to 78.86%.
India has recorded more than 82,000 recoveries for three days in a row now and the recovered cases exceed active ones by more than 3 million, according to the ministry’s data.
“These high levels of recovery have resulted in a 100% increase in the number of recovered cases in the past 30 days. Maharashtra (17,559) contributed more than one-fifth of the new recoveries (21.22%) while the States of Andhra Pradesh (10,845), Karnataka (6,580), Uttar Pradesh (6,476) and Tamil Nadu (5,768) contributed 35.87% of the new recoveries,” the health ministry said on Thursday.
It added that these states together account for 57.1% of total new recoveries.
Maharashtra accounted for more than 40% of the new deaths related to the coronavirus disease. The following four States of Uttar Pradesh (86), Punjab (78), Andhra Pradesh (64), West Bengal (61) contributed 25.5% of the fatalities in the last 24 hours, the ministry had said on Thursday.
There are more than 30 million coronavirus disease cases worldwide and 944,887 people have succumbed to the viral disease, according to Johns Hopkins University’s Covid-19 data
VA-SenaSeptember 18, 2020
“During the period of lockdown from March 24, 2020 to September 13, 2020, the district and subordinate courts across the country have disposed 15,32,334 cases,” Ravi Shankar Prasad said.
New Delhi: The district and subordinate courts across the country have disposed of over 15.32 lakh cases since the lockdown was announced in the country due to the coronavirus pandemic on March 24, the government informed Parliament on Thursday.
In a written reply to a question in the Rajya Sabha, Union Minister for Law and Justice Ravi Shankar Prasad said after the announcement of the nationwide lockdown, directions were issued from time to time by the respective high courts to the courts under their administrative jurisdiction for hearing of the urgent civil and criminal matters in the virtual or physical mode, depending on local conditions.
“During the period of lockdown from March 24, 2020 to September 13, 2020, the district and subordinate courts across the country have disposed 15,32,334 cases,” he said.
Mr Prasad said most of the high courts have further advised the district and subordinate courts that where there is no shutdown or lockdown and that they may resume normal functioning virtually or physically and take up all kinds of cases, including those pertaining to undertrial prisoners, civil cases, matrimonial disputes, child custody matters, recording of evidence and other old matters.
VA-SenaSeptember 11, 2020
China’s only nasal spray vaccine against the coronavirus is expected to start phase I clinical trials in November, and it is recruiting 100 volunteers.
Beijing: China has approved for trials its first nasal spray vaccine to combat the novel coronavirus that has claimed over 904,000 lives and infected more than 27 million people globally, official media reported.
China’s only nasal spray vaccine against the coronavirus is expected to start phase I clinical trials in November, and it is recruiting 100 volunteers.
It is the only vaccine of its type approved by China’s National Medical Products Administration, the state-run Global Times reported.
The vaccine is a collaborative mission between Hong Kong and the Chinese mainland that involves researchers from the University of Hong Kong, Xiamen University, and Beijing Wantai Biological Pharmacy.
Microbiologist from the University of Hong Kong, Yuen Kwok-yung, said the vaccine stimulates the natural infection pathway of respiratory viruses to activate the immune response.
The nasal spray vaccination could generate double protection for vaccine recipients – influenza and the novel coronavirus – if it also contains influenza viruses including H1N1, H3N2 and B, Yuen said, adding that it would take at least another year to finish the three clinical trials.
A Beijing-based immunologist told the daily that compared with injections, a nasal spray vaccination is easier to administer and would also be easy to mass-produce and distribute as it adopts the mature influenza vaccine production technology.
The nasal spray vaccine uses live attenuated influenza vaccine; the other four technical routes China is using to develop the coronavirus vaccines are inactivated vaccines, adenoviral vector-based vaccines, and DNA and mRNA vaccines. The inactivated vaccine is estimated to be the earliest to be in the market, the report said.
The immunologist said the new vaccine may not cause systemic side effects, but side effects may occur in the respiratory system such as asthma and shortness of breath.
Ideally, scientists do not expect side effects except for minor nasal obstruction or rhinorrhea, Yuen Kwok-yung said.
It is not yet clear whether immunity generated from nasal spray vaccinations will last longer than for injected vaccines, the report said.
China has approved three COVID-19 vaccine candidates for clinical trials. It has also authorised emergency usage of COVID-19 vaccines developed by some select domestic companies.
“We’ve drawn up a series of plan packages, including medical consent forms, side-effects monitoring plans, rescuing plans, compensation plans, to make sure the emergency use is well regulated and monitored,” Zheng Zhongwei, head of China’s coronavirus vaccine development task force told the official media here last month.
An emergency use authorisation, which is based on Chinese vaccine management law, allows unapproved vaccine candidates to be used among people who are at high risk of getting infected in a limited period.
The Global Times has previously reported that employees of state-owned enterprises (SOEs) preparing to go abroad and the frontline medics have been offered two choices of domestic inactivated vaccine candidates developed by Sinopharm for urgent use.
The novel coronavirus, which originated from China”s Wuhan city in December last year, has claimed 904,485 lives and infected 27,902,002 globally. The US is the worst affected country with 190,887 deaths and 6,363,729 infections, according to the Johns Hopkins University data.
VA-SenaAugust 25, 2020
Covid-19 Patient Ends Life by Jumping off Hospital Building in Bihar
A 46-year-old COVID-19 patient allegedly died by suicide by jumping off a hospital building in Bihar's Jehanabad district on Sunday, police said. The man, a resident of Kali Nagar Colony in Jehanabad town, allegedly jumped off the third floor of the GNM Nursing College building in Sadar hospital premises, Town police station SHO Nikhil Kumar said. His mother had come to meet him in the evening and he allegedly jumped off the building after some time, sources said. The man was arrested on August 18 after liquor was seized from his possession in the dry state, they said. He had tested positive for COVID-19 during mandatory testing conducted before he was to be sent to the prison, following which he was admitted to the isolation ward of the GNM Nursing College, the sources said. An investigation is underway to ascertain the reason behind the suspected suicide, Kumar said. Two COVID-19 patients, aged 21 and 32, had earlier died by suicide at AIIMS, Patna, while another 30-year-old migrant worker had hanged himself in a quarantine centre in Hajipur.
